A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients.
Cell Death Discov
; 4: 116, 2018.
Article
en En
| MEDLINE
| ID: mdl-30588338
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Año:
2018
Tipo del documento:
Article